https://www.prnewswire.com/news-releases/lilly-to-acquire-point-biopharma-to-expand-oncology-capabilities-into-next-generation-radioligand-therapies-301945243.html
0
0
Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies - PR Newswire
10/3/23 at 10:45am
Organization
PRNewswire
Authors
Details
39 words
Summarize
Pharmaceuticals & Biotech Business & Industrial POINT Biopharma Oncology Capabilities Eli Lilly PRNewswire NYSE PNT Nasdaq
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and POINT Biopharma Global, Inc. (NASDAQ: PNT) today announced a definitive agreement for Lilly to acquire...
Create an account or login to join the discussion